{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:24:18Z","timestamp":1787239458084,"version":"build-2736575974"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Optimizing antithymocyte globulin (rATG) dosage is critical for high immunological risk patients undergoing a repeat kidney transplant. This natural retrospective cohort study compared clinical outcomes of two successive cohorts of consecutive recipients of retransplants receiving 5 x 1 mg\/kg (rATG-5, n = 100) or a single 3 mg\/kg (rATG-3, n = 110) dose of rATG induction therapy. All patients had negative complement-dependent cytotoxicity crossmatch and no anti-HLA A, B, DR donor-specific antibodies (DSA). The primary endpoint was efficacy failure (first biopsy-proven acute rejection, graft loss, or death) at 12 months. There was no difference in the cumulative incidence of efficacy failure (18.0% vs. 21.8%, HR = 1.22, 95% CI 0.66\u20132.25), respectively. There were no differences in 3-years freedom from biopsy proven acute rejection, and patient, graft, and death-censored graft survivals. There were no differences in the incidence of surgical complications (25.0% vs. 18.2%; p 0.151), early hospital readmission (27.8% vs. 29.5%; p = 0.877) and CMV infections (49% vs. 40%; p = 0.190). There were also no differences in the incidence (59.6% vs. 58.7%, p = 0.897) and duration of delayed graft function but a stable difference in estimate glomerular filtration rate was observed from month 1 (54.7\u00b128.8 vs. 44.1\u00b125.3 ml\/min\/1.73 m\n                    <jats:sup>2<\/jats:sup>\n                    , p = 0.005) to month 36 (51.1\u00b127.7 vs. 42.5\u00b124.5, p = 0.019). Mean urinary protein concentration (month 36: 0.38\u00b10.81 vs. 0.70\u00b12.40 g\/ml, p = 0.008) and mean chronic glomerular Banff score in for cause biopsies (months 4\u201336: 0.0\u00b10.0 vs. 0.04\u00b10.26, p = 0.044) were higher in the rATG-3 group. This cohort analysis did not detect differences in the incidence of efficacy failure and in safety outcomes at 12 months among recipients of kidney retransplants without A, B, and DR DSA, receiving induction therapy with a single 3 mg\/kg rATG dose or the traditional 5 mg\/kg rATG.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0251384","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:44:23Z","timestamp":1620827063000},"page":"e0251384","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation"],"prefix":"10.1371","volume":"16","author":[{"given":"Kamilla","family":"Linhares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Bernardi","family":"Taddeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Pontello","family":"Cristelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Proen\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Nunes","family":"Ficher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"de Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3616-4579","authenticated-orcid":true,"given":"Maria","family":"Gerbase-DeLima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Medina-Pestana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9896-323X","authenticated-orcid":true,"given":"Helio","family":"Tedesco-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"issue":"3","key":"pone.0251384.ref001","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/ajt.15646","article-title":"Modest rates and wide variation in timely access to repeat kidney transplantation in the United States","volume":"20","author":"JD Schold","year":"2020","journal-title":"Am J Transplant"},{"issue":"6","key":"pone.0251384.ref002","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/ajt.12690","article-title":"Risk factors for retransplant kidney recipients: relisting and outcomes from patients\u2019 primary transplant","volume":"14","author":"EL Heaphy","year":"2014","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"pone.0251384.ref003","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 Annual Data Report: Kidney","volume":"21","author":"A Hart","year":"2021","journal-title":"Am J Transplant"},{"issue":"8","key":"pone.0251384.ref004","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2215\/CJN.01530219","article-title":"Access to Kidney Transplantation after a Failed First Kidney Transplant and Associations with Patient and Allograft Survival: An Analysis of National Data to Inform Allocation Policy","volume":"14","author":"S Clark","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"pone.0251384.ref005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ajt.15595","article-title":"Donor-specific antibodies detected by single antigen beads alone can help risk stratify patients undergoing retransplantation across a repeat HLA mismatch","volume":"20","author":"G Lucisano","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"pone.0251384.ref006","first-page":"Cd004759","article-title":"Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients","volume":"1","author":"P Hill","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"pone.0251384.ref007","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1111\/ajt.15342","article-title":"Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation","volume":"19","author":"RR Alloway","year":"2019","journal-title":"Am J Transplant"},{"issue":"6","key":"pone.0251384.ref008","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0000000000000507","article-title":"Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States","volume":"99","author":"J Schold","year":"2015","journal-title":"Transplantation"},{"issue":"2","key":"pone.0251384.ref009","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1097\/TXD.0000000000000765","article-title":"Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation","volume":"4","author":"N Singh","year":"2018","journal-title":"Transplant Direct"},{"key":"pone.0251384.ref010","article-title":"Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report","author":"AR Tambur","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"pone.0251384.ref011","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2215\/CJN.00700117","article-title":"Donor-Specific Antibodies in Kidney Transplant Recipients","volume":"13","author":"R Zhang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"pone.0251384.ref012","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/ajt.13327","article-title":"Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses","volume":"15","author":"H Tedesco-Silva","year":"2015","journal-title":"Am J Transplant"},{"key":"pone.0251384.ref013","article-title":"Targeted preemptive therapy according to perceived risk of CMV infection after kidney transplantation","author":"C Henrique Pinto","year":"2016","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"pone.0251384.ref014","doi-asserted-by":"crossref","first-page":"48","DOI":"10.6002\/ect.2018.0244","article-title":"Retransplant Outcomes Compared With First Kidney Transplants: Important Observations Not Reported in the Scientific Registry of Transplant Recipients Annual Report","volume":"18","author":"OK Serrano","year":"2020","journal-title":"Exp Clin Transplant."},{"issue":"2","key":"pone.0251384.ref015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/tri.13800","article-title":"Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti-thymocyte globulin without CMV prophylaxis\u2014a cohort single-center study","volume":"34","author":"MI de Paula","year":"2021","journal-title":"Transpl Int"},{"key":"pone.0251384.ref016","article-title":"The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-Risk Kidney Transplant Recipients without Pharmacological Prophylaxis","author":"MI de Paula","year":"2020","journal-title":"Transplantation"},{"issue":"10084","key":"pone.0251384.ref017","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(17)31283-7","article-title":"Strategies for long-term preservation of kidney graft function","volume":"389","author":"T Wekerle","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"pone.0251384.ref018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.tp.0000269725.74189.b9","article-title":"Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades","volume":"84","author":"G Opelz","year":"2007","journal-title":"Transplantation"},{"issue":"8","key":"pone.0251384.ref019","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/ajt.14247","article-title":"Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients","volume":"17","author":"C Wehmeier","year":"2017","journal-title":"Am J Transplant"},{"issue":"1","key":"pone.0251384.ref020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.trre.2018.08.001","article-title":"Indications, risks and impact of failed allograft nephrectomy","volume":"33","author":"L Ghyselen","year":"2019","journal-title":"Transplant Rev (Orlando)"},{"issue":"4","key":"pone.0251384.ref021","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.trim.2012.02.003","article-title":"The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients","volume":"26","author":"MM Kho","year":"2012","journal-title":"Transpl Immunol"},{"issue":"19","key":"pone.0251384.ref022","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"DC Brennan","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0251384.ref023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/TP.0000000000000821","article-title":"Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation","volume":"100","author":"T Bachelet","year":"2016","journal-title":"Transplantation"},{"issue":"3","key":"pone.0251384.ref024","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/ctr.12513","article-title":"Surgical complications after kidney transplantation: different impacts of immunosuppression, graft function, patient variables, and surgical performance","volume":"29","author":"M Koch","year":"2015","journal-title":"Clin Transplant"},{"issue":"12","key":"pone.0251384.ref025","doi-asserted-by":"crossref","first-page":"e0144188","DOI":"10.1371\/journal.pone.0144188","article-title":"Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals","volume":"10","author":"TV de Sandes-Freitas","year":"2015","journal-title":"PLoS One"},{"key":"pone.0251384.ref026","article-title":"Differential impact of delayed graft function in deceased donor renal transplant recipients with and without donor-specific HLA-antibodies","author":"J Haller","year":"2019","journal-title":"Transplantation"},{"issue":"4","key":"pone.0251384.ref027","doi-asserted-by":"crossref","first-page":"436","DOI":"10.6002\/ect.2020.0066","article-title":"Donor Age Amplifies the Detrimental Effects of Cold Ischemia Time on Long-Term Kidney Allograft Survival Independently of the Occurrence of Delayed Graft Function or Early Acute Rejection","volume":"18","author":"P Rincon Cintra da Cruz","year":"2020","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"pone.0251384.ref028","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/ctr.12191","article-title":"The effect of donor-recipient gender mismatch on short- and long-term graft survival in kidney transplantation: a systematic review and meta-analysis","volume":"27","author":"JY Zhou","year":"2013","journal-title":"Clin Transplant"},{"issue":"7","key":"pone.0251384.ref029","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2215\/CJN.09330916","article-title":"A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size","volume":"12","author":"VB Ashby","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0251384.ref030","doi-asserted-by":"crossref","first-page":"4524837","DOI":"10.1155\/2018\/4524837","article-title":"Does Rabbit Antithymocyte Globulin (Thymoglobuline\u00ae) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?","volume":"2018","author":"L Guirado","year":"2018","journal-title":"J Transplant"},{"issue":"4","key":"pone.0251384.ref031","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MOT.0000000000000325","article-title":"HLA-DQ antibodies: are they real? Are they relevant? Why so many?","volume":"21","author":"AR Tambur","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"issue":"6","key":"pone.0251384.ref032","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/TP.0000000000000031","article-title":"Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients","volume":"97","author":"MM Brokhof","year":"2014","journal-title":"Transplantation"},{"issue":"2","key":"pone.0251384.ref033","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trre.2015.12.002","article-title":"Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation\u2014A review","volume":"30","author":"J Pascual","year":"2016","journal-title":"Transplant Rev (Orlando)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:15:16Z","timestamp":1699017316000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251384"}},"subtitle":[],"editor":[{"given":"Justyna","family":"Go\u0142\u0119biewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0251384","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]}}}